Evidence map›Paper›PMID 27452664›Full record

ArticleALTEX2017

Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.

Michael Aschner, Sandra Ceccatelli, Mardas Daneshian, Ellen Fritsche, Nina Hasiwa, Thomas Hartung, Helena T Hogberg, Marcel Leist, Abby Li, William R Mundi and 7 more

Abstract read
In one paragraph

Article in ALTEX, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Testing Strategies for Metabolite-Mediated Neurotoxicity.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Organoid intelligence for developmental neurotoxicity testing.Frontiers in cellular neuroscience · 2024
    Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Michael AschnerAlbert Einstein College of Medicine, New York, USA.
Sandra CeccatelliDepartment of Neuroscience, Karolinska Institutet Stockholm, Sweden.
Mardas DaneshianCenter for Alternatives to Animal Testing-Europe (CAAT-Europe), University of Konstanz, Germany.
Ellen FritscheLeibniz Research Institute for Environmental Medicine (IUF), Düsseldorf, Germany.
Nina HasiwaCenter for Alternatives to Animal Testing-Europe (CAAT-Europe), University of Konstanz, Germany.
Thomas HartungCenter for Alternatives to Animal Testing-Europe (CAAT-Europe), University of Konstanz, Germany.
Helena T HogbergCenter for Alternatives to Animal Testing (CAAT), The Johns Hopkins University, Baltimore, MD, USA.
Marcel LeistCenter for Alternatives to Animal Testing-Europe (CAAT-Europe), University of Konstanz, Germany.
Abby LiExponent Inc.,San Francisco, USA.
William R MundiUnited States Environmental Protection Agency (USEPA), NHEERL, Research Triangle Park, NC, USA.
Stephanie PadillaUnited States Environmental Protection Agency (USEPA), NHEERL, Research Triangle Park, NC, USA.
Aldert H PiersmaNational Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Anna Bal-PriceEuropean Commission Joint Research Centre, Institute for Health and Consumer Protection, Ispra, Italy.
Andrea SeilerFederal Institute for Risk Assessment (BfR), Berlin, Germany.
Remco H WesterinkNeurotoxicology Research Group, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.
Bastian ZimmerAxiogenesis AG, Köln, Germany.
Pamela J LeinCenter for Research on Occupational and Environmental Toxicology, Oregon Health & Science University, Portland, USA.

Funding

UC Davis Center for Children's Environmental Health (CCEH)P01ES011269 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI VAN DE WATER, JUDY A. · 2001 to 2018
$12.5M
Mechanisms of Manganese NeurotoxicityR01ES010563 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 2001 to 2026
$11.9M
Mechanisms of Methylmercury Induced Neuron ToxicityR01ES007331 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 1996 to 2026
$10.6M
Molecular and Cellular Basis of PCB Developmental Neurotoxicity: ViCTER supplementR01ES014901 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HANS-JOACHIM LEHMLER, Pamela J Lein · 2009 to 2026
$9.3M
Genetic Modulation of MeHg-Induced Oxidative Stress in the Developing BrainR01ES020852 · NIEHS · VANDERBILT UNIVERSITY · PI ASCHNER, MICHAEL · 2012 to 2016
$1.8M
NIEHS NIH HHS P01 ES011269NIEHS NIH HHS R01 ES007331NIEHS NIH HHS R01 ES010563NIEHS NIH HHS R01 ES014901NIEHS NIH HHS R01 ES020852
6 · The paper itself

Abstract

There is a paucity of information concerning the developmental neurotoxicity (DNT) hazard posed by industrial and environmental chemicals. New testing approaches will most likely be based on batteries of alternative and complementary (non-animal) tests. As DNT is assumed to result from the modulation of fundamental neurodevelopmental processes (such as neuronal differentiation, precursor cell migration or neuronal network formation) by chemicals, the first generation of alternative DNT tests target these processes. The advantage of such types of assays is that they capture toxicants with multiple targets and modes-of-action. Moreover, the processes modelled by the assays can be linked to toxicity endophenotypes, i.e., alterations in neural connectivity that form the basis for neurofunctional deficits in man. The authors of this review convened in a workshop to define criteria for the selection of positive/negative controls, to prepare recommendations on their use, and to initiate the setup of a directory of reference chemicals. For initial technical optimization of tests, a set of > 50 endpoint-specific control compounds was identified. For further test development, an additional "test" set of 33 chemicals considered to act directly as bona fide DNT toxicants is proposed, and each chemical is annotated to the extent it fulfills these criteria. A tabular compilation of the original literature used to select the test set chemicals provides information on statistical procedures, and toxic/non-toxic doses (both for pups and dams). Suggestions are provided on how to use the > 100 compounds (including negative controls) compiled here to address specificity, adversity and use of alternative test systems.

Indexed as

Animal Testing AlternativesAnimalsCongresses as TopicDrug Evaluation, PreclinicalFemaleHazardous SubstancesHumansMaleNeuronsNeurotoxicity SyndromesNeurotoxinsPregnancyPrenatal Exposure Delayed EffectsToxicity TestsHazardous SubstancesNeurotoxinsAOPneurotoxicityspecificitytest developmentvalidation

Identifiers

PMID27452664
PMCPMC5250586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.